Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « ISSN » - entrée « 1878-1705 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1878-0334 < 1878-1705 < 1878-3503  Facettes :

List of bibliographic references indexed by 1878-1705

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000159 (2021) Masoud Solaymani-Dodaran [Iran] ; Mostafa Ghanei [Iran] ; Mehdi Bagheri [Iran] ; Ali Qazvini [Iran] ; Ensieh Vahedi [Iran] ; Seyed Hassan Saadat [Iran] ; Seyed Amin Setarehdan [Iran] ; Akram Ansarifar [Iran] ; Hossein Biganeh [Iran] ; Arash Mohazzab [Iran] ; Davood Khalili [Iran] ; Amir Hosein Ghazale [Iran] ; Mohammad Reza Heidari [Iran] ; Ali Taheri [Iran] ; Maliheh Khoramdad [Iran] ; Mohammad Mahdi Asadi [Iran] ; Masoud Nazemieh [Iran] ; Mojtaba Varshochi [Iran] ; Samaneh Abbasian [Iran] ; Ali Bakhtiari [Iran] ; Reza Mosaed [Iran] ; Seyyed-Javad Hosseini-Shokouh [Iran] ; Masoume Shahrokhi [Iran] ; Zeynab Yassin [Iran] ; Mohammad Ali Zohal [Iran] ; Maryam Qaraati [Iran] ; Nafiseh Rastgoo [Iran] ; Ramin Sami [Iran] ; Mohammad Javad Eslami [Iran] ; Akram Asghari [Iran] ; Mansoor Namazi [Iran] ; Shadi Ziaie [Iran] ; Raana Jafari-Moghaddam [Iran] ; Saeid Kalantari [Iran] ; Mohammad Memarian [Iran] ; Javad Khodadadi [Iran] ; Mohammad Hossein Afshari [Iran] ; Mansooreh Momen-Heravi [Iran] ; Niusha Behzadseresht [Iran] ; Ahmad Reza Mobayen [Iran] ; Abolfazl Mozafari [Iran] ; Fatemeh Movasaghi [Iran] ; Maryam Haddadzadeh Shoushtari [Iran] ; Javad Moazen [Iran]Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
000508 (2021) Payam Tabarsi [Iran] ; Saghar Barati [Iran] ; Hamidreza Jamaati [Iran] ; Sara Haseli [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Zahra Abtahian [Iran] ; Alireza Dastan [États-Unis] ; Sahar Yousefian [Iran] ; Raha Eskandari [Iran] ; Ali Saffaei [Iran] ; Fatemeh Monjazebi [Iran] ; Abdolbaset Vahedi [Iran] ; Farzaneh Dastan [Iran]Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
000610 (2021) Majid Mokhtari [Iran] ; Minoo Mohraz [Iran] ; Mohammad Mehdi Gouya [Iran] ; Hengameh Namdari Tabar [Iran] ; Jafar-Sadegh Tabrizi [Iran] ; Katayoun Tayeri [Iran] ; Saeide Aghamohamadi [Iran] ; Zahra Rajabpoor [Iran] ; Manoochehr Karami [Iran] ; Alireza Raeisi [Iran] ; Hamid Rahmani [Iran] ; Hossein Khalili [Iran]Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.
000774 (2021) Arif Kivrak [Turquie] ; Berdan Ula [Turquie] ; Hilal Kivrak [Turquie]A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2.
000B95 (2020) Farzaneh Dastan [Iran] ; Seyed Alireza Nadji [Iran] ; Ali Saffaei [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Hamidreza Jamaati [Iran] ; Seyed Mohammadreza Hashemian [Iran] ; Parvaneh Baghaei [Iran] ; Atefeh Abedini [Iran] ; Mohammad Varahram [Iran] ; Sahar Yousefian [Iran] ; Payam Tabarsi [Iran]Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial.
001044 (2020) Hamid Rahmani [Iran] ; Effat Davoudi-Monfared [Iran] ; Anahid Nourian [Iran] ; Hossein Khalili [Iran] ; Nooshin Hajizadeh [Iran] ; Narjes Zarei Jalalabadi [Iran] ; Mohammad Reza Fazeli [Iran] ; Monireh Ghazaeian [Iran] ; Mir Saeed Yekaninejad [Iran]Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial.
001105 (2020) Mahdieh Razmi [Iran] ; Farideh Hashemi [Iran] ; Elmira Gheytanchi [Iran] ; Masoumeh Dehghan Manshadi [Iran] ; Roya Ghods [Iran] ; Zahra Madjd [Iran]Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.
001943 (2020) Ali Nili [Iran] ; Ehsan Zarei [Iran] ; Azin Ghamari [Iran] ; Ali Salehi Farid [Iran] ; Soheil Tavakolpour [États-Unis] ; Maryam Daneshpazhooh [Iran] ; Hamidreza Mahmoudi [Iran]Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1878-1705" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1878-1705" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1878-1705
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021